Glenmark Pharmaceuticals Ltd. India
Organisation
Trials
Collaborator, Phase 3, Completed, 306 people, 31 Oct 2022
Phase 3, Completed, 1,110 people, 10 Nov 2015
Phase 1, Completed, 76 people, 2 Jul 2014
Sources: clinicaltrials.gov
Organisation
Collaborator, Phase 3, Completed, 306 people, 31 Oct 2022
Phase 3, Completed, 1,110 people, 10 Nov 2015
Phase 1, Completed, 76 people, 2 Jul 2014
Sources: clinicaltrials.gov